Prospective, Single Blind, Rand Controlled Study to Evaluate the Safety & Effectiveness of Tryton Side Branch Stent Used With DES Treatment of de Novo Bifurcation Lesions in MB & SB in Native Coronaries (TRYTON)

The Tryton Side Branch Stent System has been designed to address the procedural difficulty surrounding treatment of bifurcation lesions and to ensure patency of the side branch with similar performance capabilities (e.g., tracking, radiopacity, coverage and radial strength) that are currently available with conventional coronary stents designed for straight (non-bifurcation) lesions.

Stanford is currently not accepting patients for this trial.